Form 4: Repligen Corp Director Margaret Pax Reports Acquisition of Restricted Stock Units and Stock Options

Director Margaret Pax reported the acquisition of 701 restricted stock units and 1,376 stock options in Repligen Corp on May 16, 2024.

Summary

• On May 16, 2024, Margaret Pax, a director of Repligen Corp, acquired 701 restricted stock units (RSUs) and 1,376 stock options.
• The RSUs vest on the earlier of May 16, 2025, or the date of the next annual meeting of the company's shareholders.
• Each RSU represents a contingent right to receive one share of Repligen Corporation's common stock.
• The stock options have an exercise price of $171.03 and expire on May 16, 2034, vesting fully on the earlier of May 16, 2025, or the date of the next annual meeting.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock options and restricted stock units granted to a director, which is a common practice.

Positives

• The acquisition of RSUs and stock options by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the RSUs and stock options is contingent upon future events, specifically the earlier of May 16, 2025, or the date of the next annual meeting of the company's shareholders.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in the holdings of a director at Repligen Corp, a company in the biotechnology sector.

Stakeholder Impact

• The acquisition of RSUs and stock options by a director can be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates